Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Lau Raket

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Statistics in Medicine|September 17, 2022
Progression models for repeated measures: Estimating novel treatment effects in progressive diseasesLars Lau Raket
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersLars Lau Raket
Frontiers in Big Data|March 11, 2021
Statistical Disease Progression Modeling in Alzheimer DiseaseLars Lau Raket
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 30, 2026
Cognitive Trajectories from Preclinical Alzheimer's Disease to DementiaFredrik Öhman, Lars Lau Raket, Michael Schöll, et al.
Frontiers in Digital Health|March 3, 2023
Editorial: Digital brain healthLars Lau Raket, Paula Petcu, Katarzyna Wac, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 29, 2024
Scenarios for the long-term efficacy of amyloid-targeting therapies in the context of the natural history of Alzheimer's diseaseLars Lau Raket, Jeffrey Cummings, Alexis Moscoso, et al.
Brain Communications|July 19, 2023
Longitudinal changes in hippocampal texture from healthy aging to Alzheimer's diseaseAlfie Wearn, Lars Lau Raket, D Louis Collins, et al.
Plos Computational Biology|September 23, 2016
Separating Timing, Movement Conditions and Individual Differences in the Analysis of Human MovementLars Lau Raket, Britta Grimme, Gregor Schöner, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 30, 2020
Utility of plasma neurofilament light and total tau for clinical trials in Alzheimer's diseaseLars Lau Raket, Line Kühnel, Ellen Schmidt, et al.
Scientific Reports|January 12, 2022
Impact of age at onset on symptom profiles, treatment characteristics and health-related quality of life in Parkinson's diseaseLars Lau Raket, Daniel Oudin Åström, Jenny M Norlin, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Statistics in Medicine|September 17, 2022
Progression models for repeated measures: Estimating novel treatment effects in progressive diseasesLars Lau Raket
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersLars Lau Raket
Frontiers in Big Data|March 11, 2021
Statistical Disease Progression Modeling in Alzheimer DiseaseLars Lau Raket
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 30, 2026
Cognitive Trajectories from Preclinical Alzheimer's Disease to DementiaFredrik Öhman, Lars Lau Raket, Michael Schöll, et al.
Frontiers in Digital Health|March 3, 2023
Editorial: Digital brain healthLars Lau Raket, Paula Petcu, Katarzyna Wac, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 29, 2024
Scenarios for the long-term efficacy of amyloid-targeting therapies in the context of the natural history of Alzheimer's diseaseLars Lau Raket, Jeffrey Cummings, Alexis Moscoso, et al.
Brain Communications|July 19, 2023
Longitudinal changes in hippocampal texture from healthy aging to Alzheimer's diseaseAlfie Wearn, Lars Lau Raket, D Louis Collins, et al.
Plos Computational Biology|September 23, 2016
Separating Timing, Movement Conditions and Individual Differences in the Analysis of Human MovementLars Lau Raket, Britta Grimme, Gregor Schöner, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 30, 2020
Utility of plasma neurofilament light and total tau for clinical trials in Alzheimer's diseaseLars Lau Raket, Line Kühnel, Ellen Schmidt, et al.
Scientific Reports|January 12, 2022
Impact of age at onset on symptom profiles, treatment characteristics and health-related quality of life in Parkinson's diseaseLars Lau Raket, Daniel Oudin Åström, Jenny M Norlin, et al.
Pageof 4